Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Fatigue is a non-motor symptom of high prevalence in Parkinson's disease (PD); however, it is still unknown and neglected by health professionals.ObjectiveThis study aimed to demonstrate the prevalence of fatigue in patients with PD after excluding confounding factors, as well as its correlation with clinical and demographic data, and to find its negative impact on the quality of life of these patients.MethodsA cross-sectional study was carried out with 237 randomly selected patients. According to inclusion and exclusion criteria, we selected 53 patients, who were then submitted to the Fatigue Severity Scale. Clinical and demographic data were also analyzed, comparing them between patients with and without fatigue.ResultsWe identified fatigue in 21 (39.62%) patients. Patients with and without fatigue had similar mean scores on the UPDRS-III (p=0.36), equivalent daily dose of levodopa (p=0.94), mean disease duration (p=0.43), and mean age (pConclusionsFatigue is a highly prevalent and independent symptom of PD. There is no correlation between age, mean duration of disease, motor impairment, and its presence. It has a negative impact on quality of life.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.